Unravelling mechanisms of resistance to targeted drugs

Prof Salvatore Siena – Niguarda Ca’ Granda Hospital, Milan, Italy
Unravelling mechanisms of resistance to targeted drugs ( Prof Salvatore Siena – Niguarda Ca’ Granda Hospital, Milan, Italy )
17 Jul 2012

CORRECT study data prompts US FDA priority review

Prof Alberto Sobrero – Ospedale San Martino, Genova, Italy
CORRECT study data prompts US FDA priority review ( Prof Alberto Sobrero – Ospedale San Martino, Genova, Italy )
17 Jul 2012

Anti-angiogenic trials; key highlights of the 14th WCGC

Prof Eric Van Cutsem – University Hospital Leuven, Gasthuisberg, Belgium
Anti-angiogenic trials; key highlights of the 14th WCGC ( Prof Eric Van Cutsem – University Hospital Leuven, Gasthuisberg, Belgium )
17 Jul 2012

Epigenetics of cancer and changes in DNA modification in tumours

Prof Manel Esteller – University of Barcelona, Catalonia, Spain
Epigenetics of cancer and changes in DNA modification in tumours  ( Prof Manel Esteller – University of Barcelona, Catalonia, Spain   )
16 Jul 2012

Perifosine disappoints in refractory mCRC

Dr Johanna Bendell – Sarah Cannon Research Institute, Nashville, USA
Perifosine disappoints in refractory mCRC ( Dr Johanna Bendell – Sarah Cannon Research Institute, Nashville, USA )
16 Jul 2012

Screening and specialist nurses central to patient care

Jola Gore-Booth – EuropaColon, France / UK
Screening and specialist nurses central to patient care ( Jola Gore-Booth – EuropaColon, France / UK )
16 Jul 2012

Tivantinib first drug to have overall survival benefit as second-line hepatocellular carcinoma treatment

Dr Camillo Porta – Fondazione IRCCS Policlinico Universitario San Matteo, Pavia, Italy
Tivantinib first drug to have overall survival benefit as second-line hepatocellular carcinoma treatment ( Dr Camillo Porta – Fondazione IRCCS Policlinico Universitario San Matteo, Pavia, Italy )
16 Jul 2012

Adjuvant cetuximab disappoints again in mCRC

Prof Michel Ducreux – Institut Gustave Roussy, Villejuif, France
Adjuvant cetuximab disappoints again in mCRC ( Prof Michel Ducreux – Institut Gustave Roussy, Villejuif, France )
16 Jul 2012

Young Voices United against CRC

Dr Dino Tarabar – Military Medical Academy, Belgrade, Serbia
Young Voices United against CRC ( Dr Dino Tarabar – Military Medical Academy, Belgrade, Serbia )
16 Jul 2012

Advances in radiotherapy for rectal cancer

Dr Karin Haustermans – University Hospital Leuven, Belgium
Advances in radiotherapy for rectal cancer  ( Dr Karin Haustermans – University Hospital Leuven, Belgium )
16 Jul 2012

Important to support young medical oncologists’ research

Prof Roberto Labianca – Riuniti Hospital, Bergamo, Italy
Important to support young medical oncologists’ research  ( Prof Roberto Labianca – Riuniti Hospital, Bergamo, Italy )
16 Jul 2012

Role of family history and genetic testing in diagnosis

Dr Marie Wood – University of Vermont, Burlington, USA
Role of family history and genetic testing in diagnosis  ( Dr Marie Wood – University of Vermont, Burlington, USA )
15 Jun 2012